Low Dose for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
BAMF Health, Grand Rapids, MIProstate Cancerilluccix 68Ga-PSMA-11 Total Body PET-CT - Drug
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial will use Illuccix to establish a standard scanning protocol for PET-CT imaging on the United Imaging scanner uEXPLORER.

Eligible Conditions
  • Metastatic Castration Resistant Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Diagnostic (fluciclovine F18 PET/CT)
1
Biopsy of Prostate
1
Catheterization

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 months

3 months
Comparing the imaging quality using low dose and high dose Ga-68 PSMA-11 at various scan lengths.

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Diagnostic (fluciclovine F18 PET/CT)
1
Biopsy of Prostate
1
Catheterization

Trial Design

2 Treatment Groups

Low Dose
1 of 2
High dose
1 of 2

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Low Dose · No Placebo Group · Phase < 1

Low Dose
Drug
Experimental Group · 1 Intervention: illuccix 68Ga-PSMA-11 Total Body PET-CT · Intervention Types: Drug
High dose
Drug
Experimental Group · 1 Intervention: illuccix 68Ga-PSMA-11 Total Body PET-CT · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months

Who is running the clinical trial?

BAMF HealthLead Sponsor
Telix International Pty LtdIndustry Sponsor
13 Previous Clinical Trials
1,098 Total Patients Enrolled
1 Trials studying Prostate Cancer
50 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are being considered for initial treatment because doctors suspect that the cancer has spread to other parts of your body.
References

Frequently Asked Questions

Are there any openings in this trial for participants at the present time?

"Per the information hosted on clinicaltrials.gov, it appears that this particular trial is not currently recruiting participants, despite having been posted initially on October 1st 2022 and edited most recently on September 26th 2022. Although recruitment has ceased for this study, there are still 1258 other trials actively seeking patients at present." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top